212 related articles for article (PubMed ID: 15196573)
1. Human antibody response to surface layer proteins in Clostridium difficile infection.
Drudy D; Calabi E; Kyne L; Sougioultzis S; Kelly E; Fairweather N; Kelly CP
FEMS Immunol Med Microbiol; 2004 Jul; 41(3):237-42. PubMed ID: 15196573
[TBL] [Abstract][Full Text] [Related]
2. Asymptomatic carriage of Clostridium difficile and serum levels of IgG antibody against toxin A.
Kyne L; Warny M; Qamar A; Kelly CP
N Engl J Med; 2000 Feb; 342(6):390-7. PubMed ID: 10666429
[TBL] [Abstract][Full Text] [Related]
3. Passive immunisation of hamsters against Clostridium difficile infection using antibodies to surface layer proteins.
O'Brien JB; McCabe MS; Athié-Morales V; McDonald GS; Ní Eidhin DB; Kelleher DP
FEMS Microbiol Lett; 2005 May; 246(2):199-205. PubMed ID: 15899406
[TBL] [Abstract][Full Text] [Related]
4. Association between IgG2 and IgG3 subclass responses to toxin A and recurrent Clostridium difficile-associated disease.
Katchar K; Taylor CP; Tummala S; Chen X; Sheikh J; Kelly CP
Clin Gastroenterol Hepatol; 2007 Jun; 5(6):707-13. PubMed ID: 17544998
[TBL] [Abstract][Full Text] [Related]
5. Active immunization of hamsters against Clostridium difficile infection using surface-layer protein.
Ní Eidhin DB; O'Brien JB; McCabe MS; Athié-Morales V; Kelleher DP
FEMS Immunol Med Microbiol; 2008 Mar; 52(2):207-18. PubMed ID: 18093141
[TBL] [Abstract][Full Text] [Related]
6. Association of interleukin-8 polymorphism and immunoglobulin G anti-toxin A in patients with Clostridium difficile-associated diarrhea.
Jiang ZD; Garey KW; Price M; Graham G; Okhuysen P; Dao-Tran T; LaRocco M; DuPont HL
Clin Gastroenterol Hepatol; 2007 Aug; 5(8):964-8. PubMed ID: 17618838
[TBL] [Abstract][Full Text] [Related]
7. Serum anti-toxin B antibody correlates with protection from recurrent Clostridium difficile infection (CDI).
Leav BA; Blair B; Leney M; Knauber M; Reilly C; Lowy I; Gerding DN; Kelly CP; Katchar K; Baxter R; Ambrosino D; Molrine D
Vaccine; 2010 Jan; 28(4):965-9. PubMed ID: 19941990
[TBL] [Abstract][Full Text] [Related]
8. Clostridium difficile-associated diarrhea in heart transplant recipients: is hypogammaglobulinemia the answer?
Muñoz P; Giannella M; Alcalá L; Sarmiento E; Fernandez Yañez J; Palomo J; Catalán P; Carbone J; Bouza E
J Heart Lung Transplant; 2007 Sep; 26(9):907-14. PubMed ID: 17845929
[TBL] [Abstract][Full Text] [Related]
9. Colonic IgA producing cells and macrophages are reduced in recurrent and non-recurrent Clostridium difficile associated diarrhoea.
Johal SS; Lambert CP; Hammond J; James PD; Borriello SP; Mahida YR
J Clin Pathol; 2004 Sep; 57(9):973-9. PubMed ID: 15333661
[TBL] [Abstract][Full Text] [Related]
10. Diminished intestinal colonization by Clostridium difficile and immune response in mice after mucosal immunization with surface proteins of Clostridium difficile.
Péchiné S; Janoir C; Boureau H; Gleizes A; Tsapis N; Hoys S; Fattal E; Collignon A
Vaccine; 2007 May; 25(20):3946-54. PubMed ID: 17433506
[TBL] [Abstract][Full Text] [Related]
11. Association between antibody response to toxin A and protection against recurrent Clostridium difficile diarrhoea.
Kyne L; Warny M; Qamar A; Kelly CP
Lancet; 2001 Jan; 357(9251):189-93. PubMed ID: 11213096
[TBL] [Abstract][Full Text] [Related]
12. Systemic antibody response to Clostridium difficile in colonized patients with and without symptoms and matched controls.
Sánchez-Hurtado K; Corretge M; Mutlu E; McIlhagger R; Starr JM; Poxton IR
J Med Microbiol; 2008 Jun; 57(Pt 6):717-724. PubMed ID: 18480328
[TBL] [Abstract][Full Text] [Related]
13. Active and passive immunization against Clostridium difficile diarrhea and colitis.
Giannasca PJ; Warny M
Vaccine; 2004 Feb; 22(7):848-56. PubMed ID: 15040937
[TBL] [Abstract][Full Text] [Related]
14. [Recurrence of Clostridium difficile-associated diarrhoea prevented by the administration of a whey concentrate from specifically immunised cows; prospective study].
Bauer MP; Numan-Ruberg SC; Bredewold OW; Kuijper EJ; Mooi-Kokenberg EA; Debast SB; van Dissel JT
Ned Tijdschr Geneeskd; 2008 Aug; 152(35):1919-26. PubMed ID: 18808082
[TBL] [Abstract][Full Text] [Related]
15. Mortality of patients with antibiotic-associated diarrhoea: the impact of Clostridium difficile.
Bishara J; Peled N; Pitlik S; Samra Z
J Hosp Infect; 2008 Apr; 68(4):308-14. PubMed ID: 18353491
[TBL] [Abstract][Full Text] [Related]
16. Community-onset Clostridium difficile-associated diarrhoea not associated with antibiotic usage--two case reports with review of the changing epidemiology of Clostridium difficile-associated diarrhoea.
Bauer MP; Goorhuis A; Koster T; Numan-Ruberg SC; Hagen EC; Debast SB; Kuijper EJ; van Dissel JT
Neth J Med; 2008 May; 66(5):207-11. PubMed ID: 18490799
[TBL] [Abstract][Full Text] [Related]
17. Clostridium difficile-associated diarrhoea.
Elliott B; Chang BJ; Golledge CL; Riley TV
Intern Med J; 2007 Aug; 37(8):561-8. PubMed ID: 17640189
[TBL] [Abstract][Full Text] [Related]
18. Variability of Clostridium difficile surface proteins and specific serum antibody response in patients with Clostridium difficile-associated disease.
Péchiné S; Janoir C; Collignon A
J Clin Microbiol; 2005 Oct; 43(10):5018-25. PubMed ID: 16207956
[TBL] [Abstract][Full Text] [Related]
19. Epidemiology and incidence of Clostridium difficile-associated diarrhoea diagnosed upon admission to a university hospital.
Price MF; Dao-Tran T; Garey KW; Graham G; Gentry LO; Dhungana L; Dupont HL
J Hosp Infect; 2007 Jan; 65(1):42-6. PubMed ID: 17145108
[TBL] [Abstract][Full Text] [Related]
20. A randomized, double-blind study comparing Clostridium difficile immune whey and metronidazole for recurrent Clostridium difficile-associated diarrhoea: efficacy and safety data of a prematurely interrupted trial.
Mattila E; Anttila VJ; Broas M; Marttila H; Poukka P; Kuusisto K; Pusa L; Sammalkorpi K; Dabek J; Koivurova OP; Vähätalo M; Moilanen V; Widenius T
Scand J Infect Dis; 2008; 40(9):702-8. PubMed ID: 19086244
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
